期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 16, 期 8, 页码 18185-18223出版社
MDPI
DOI: 10.3390/ijms160818185
关键词
cardiovascular disease; endothelial dysfunction; oxidative stress; inflammation; dipeptidyl peptidase-4 inhibitors; glucagon-like peptide analogs
资金
- Boehringer Ingelheim Pharma GmbH Co. KG
- Mainzer Herz Stiftung
- Center for Translational Vascular Biology (CTVB)
- Center of Thrombosis and Hemostasis (Mainz, Germany) - Federal Ministry of Education and Research [BMBF 01EO1003]
- European Cooperation in Science and Technology (COST Action) [BM1203/EU-ROS]
Cardiovascular disease is a leading cause of death and reduced quality of life worldwide. Arterial vessels are a primary target for endothelial dysfunction and atherosclerosis, which is accompanied or even driven by increased oxidative stress. Recent research in this field identified different sources of reactive oxygen and nitrogen species contributing to the pathogenesis of endothelial dysfunction. According to lessons from the past, improvement of endothelial function and prevention of cardiovascular disease by systemic, unspecific, oral antioxidant therapy are obviously too simplistic an approach. Source- and cell organelle-specific antioxidants as well as activators of intrinsic antioxidant defense systems might be more promising. Since basic research demonstrated the contribution of different inflammatory cells to vascular oxidative stress and clinical trials identified chronic inflammatory disorders as risk factors for cardiovascular events, atherosclerosis and cardiovascular disease are closely associated with inflammation. Therefore, modulation of the inflammatory response is a new and promising approach in the therapy of cardiovascular disease. Classical anti-inflammatory therapeutic compounds, but also established drugs with pleiotropic immunomodulatory abilities, demonstrated protective effects in various models of cardiovascular disease. However, results from ongoing clinical trials are needed to further evaluate the value of immunomodulation for the treatment of cardiovascular disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据